Adeno-associated viral vectors can deliver gene therapies, but AAV-neutralizing antibodies might prevent the medicines from working.

The International Commission on the Clinical Use of Human Germline Genome Editing claims the technology is still too risky for therapeutic use.

Researchers are adapting CRISPR, synthetic biology, and other creative approaches to detect SARS-CoV-2 nucleic acids outside of the lab or doctors’ offices, in the hopes of making diagnostics more affordable and accessible.

An enzyme pulled from toxic bacteria can enter the organelle and perform single-nucleotide DNA swaps.

Three studies identify unintended consequences of gene editing in human embryos, including large deletions and reshuffling of DNA.

10x Genomics invites you to join them for an educational webinar.

Researchers slowed disease progression in the mice by injecting two different viral vectors, each containing one part of the DNA encoding the Cas9 protein, to edit the causative gene.

Discover high-throughput screening and profiing technologies to find and characterize novel therapeutic targets and drugs.